Physician profile
Edward Galena
NPI 1548269640
$649.75
in general payments reported to CMS, 2019-2025
12 companies · $59.05 in 2025
The $59.05 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $133 · 2021: $122 · 2022: $60.73 · 2023: $45.17 · 2024: $16.97 · 2025: $59.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $167.14 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $149.85 | 2019-2023 | Vaqta, Gardasil 9, Vaxneuvance |
| Kaleo, INC. | $86.24 | 2019-2021 | |
| Pfizer INC. | $62.20 | 2019 | |
| Supernus Pharmaceuticals, INC. | $49.90 | 2022-2023 | Qelbree |
| Sanofi Pasteur INC. | $30.03 | 2021-2022 | |
| Insulet Corporation | $27.37 | 2025 | Omnipod |
| Cranial Technologies, INC | $18.58 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $15.50 | 2025 | Neffy |
| Adlon Therapeutics L.P. | $14.92 | 2019 | |
| Mission Pharmacal Company | $14.07 | 2019 | |
| Ironshore Pharmaceuticals INC. | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Galena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.